Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial.
Cooper, D James
Data Interpretation, Statistical
Outcome Assessment (Health Care)
MetadataShow full item record
CitationErythropoietin in traumatic brain injury: study protocol for a randomised controlled trial. 2015, 16:39 Trials
AbstractTraumatic brain injury is a leading cause of death and disability worldwide. Laboratory and clinical studies demonstrate a possible beneficial effect of erythropoietin in improving outcomes in the traumatic brain injury cohort. However, there are concerns regarding the association of erythropoietin and thrombosis in the critically ill. A large-scale, multi-centre, blinded, parallel-group, placebo-controlled, randomised trial is currently underway to address this hypothesis.